Table 2. Clinical demographics and hospital course for patients transfused CCP.

General Clinical Demographics
Age (mean ± SD)	60.2 ± 13.7 years (median 61, range 22–89 years)
Gender (N (% total group))	Male 22 (50%) Female 22 (50%)
ABO Blood Type (N (% total group))	A 16 (36%) B 1 (2%) AB 2 (5%) O 25 (57%)
Rh (N (% total group))	Positive 36 (82%) Negative 8 (18%)
Admission and Hospitalization Details
Residence Prior to Admission	Home (self-care) 35 (80%) Skilled Nursing Facility 9 (20%)
Duration of Symptoms Prior to Admission (mean ± SD)	8.3 ± 5 days (median 7, range 2–28 days)
COVID-19 Disease Status on Admission	Severe Disease 36 (82%) Life-Threatening Disease 8 (18%)
Hospital Course of COVCID-19
Escalation of Oxygen Requirements	YES 16 (36%) NO 18 (41%) Escalation on admit 10 (23%) (Escalation within 24 hours of Admission)
Admission to Escalation in days (mean ± SD)	3.9 ± 3.0 days (median 3.0, range 1–10 days)
Intubation/Mechanical Ventilation	YES 17 (39%) NO 27 (61%)
Duration of Mechanical Ventilation in days (mean ± SD, excludes 5 deaths while ventilated)	10.5 + 8.4 days (median 7, range 1–24 days)
Admission to Respiratory Improvement in days (mean ± SD)	7.9 + 5.4 days (median 6.0, range 1–23 days)
Other Treatments rendered	Hydroxychloroquine 10 (23%) Systemic Steroids 22 (50%) Remdesivir 22 (50%) Antibiotics 27 (67%) Vassopressors 14 (32%)
Outcome/Discharge Details
Length of Stay (mean ± SD)	15.8 ± 11.3 days (median 10.5, range 3–40 days)
Discharge Status	Home Self-care 23 (52%) Skilled Nursing Facility 11 (25%) Rehab. Facility 3 (7%) DIED (in-hospital death) 7 (16%)
Oxygen Requirements at Discharge	None 28 (64%) NC O2 7 (16% Died 7 (16%)